Skip to main content
logo
PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.190
+0.040 (3.48%)
At close: Jun 26, 2026, 4:00 PM EDT
1.210
+0.020 (1.68%)
After-hours: Jun 26, 2026, 4:13 PM EDT

PMV Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
39.1337.9840.8838.53109.12173.29
Short-Term Investments
54.4274.96128.58165.35132.76124.7
Cash & Short-Term Investments
93.55112.94169.45203.88241.88297.99
Cash Growth
-41.67%-33.35%-16.89%-15.71%-18.83%-17.55%
Other Current Assets
2.232.286.23.535.133.3
Total Current Assets
95.78115.23175.66207.41247.01301.29
Net Property, Plant & Equipment
0.491.041.5519.0520.4913.15
Long-Term Investments
--13.8425.512.516.91
Other Long-Term Assets
0.30.30.240.190.310.22
Total Assets
96.56116.56191.29252.15270.31331.57
Accounts Payable
1.633.166.583.2433.19
Accrued Expenses
6.677.867.449.947.318.63
Current Portion of Leases
0.290.40.350.850.530.4
Total Current Liabilities
8.611.4214.3714.0310.8312.22
Long-Term Leases
-0.440.8412.4313.4510.79
Total Long-Term Liabilities
-0.440.8412.4313.4510.79
Total Liabilities
8.611.8515.2126.4624.2823.01
Additional Paid-in Capital
552.47551.08544.65535.47487.52476.36
Accumulated Other Comprehensive Income
-0.020.080.140.22-0.45-0.08
Retained Earnings
-464.49-446.45-368.71-310-241.04-167.73
Shareholders' Equity
87.97104.71176.08225.69246.03308.56
Total Liabilities & Equity
96.56116.56191.29252.15270.31331.57
Total Debt
0.290.841.1913.2913.9811.19
Net Cash (Debt)
93.26112.11168.26190.59227.9286.79
Net Cash Growth
-16.81%-33.38%-11.72%-16.37%-20.54%-20.65%
Net Cash Per Share
1.762.133.263.975.006.35
Book Value
87.97104.71176.08225.69246.03308.56
Book Value Per Share
1.661.993.414.705.406.84
Tangible Book Value
87.97104.71176.08225.69246.03308.56
Tangible Book Value Per Share
1.661.993.414.705.406.84
SEC Filings: 10-K · 10-Q